












Abstract: The production and trafficking of illicit 
drugs poses complex and interlinked problems, 
which have a negative impact on public health 
and the security and stability of society. In 
responding to the dynamics of a globalised drug 
market, the EU and its partners are involved in 
actions within and outside the EU. Focusing on 
actions directed at the EU’s internal security 
situation, this paper elaborates who is involved in 
setting policy, what legal and funding basis for 
action has been established, and what the main 
priorities are. In doing so, the paper looks at the 
EU institutions (the Parliament, the European 
Council, the Council and the Commission) and 
agencies predominately involved in the 
management of drug supply reduction and 
internal security issues. The paper explores 
relevant EU treaties and legislations that provide 
a means to target the supply of illicit drugs, as 
well as the financial instruments and 
programmes supporting this action. Additionally, 
this paper also discusses how these policy areas 
are addressed in the EU’s strategic planning 
documents. For example, the Stockholm 
Programme, the EU internal security strategy, the 
EU policy cycle for organised and serious 
international crime and the EU drugs strategy 
2013–20 and action plan 2013–16. 
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aimed at detecting and disrupting the cultivation, production, 
shipment, distribution and sale of illicit drugs and the profits 
derived from these activities, both inside and outside the EU. 
Internal security issues can be defined as problems that 
threaten to undermine the EU’s stability and the health and 
safety of its citizens through, among other things, the 
operation of supply routes for illicit commodities (e.g. drugs) 
and illicit markets for their sale. The EU internal security 
strategy defines organised and serious crime and drug 
trafficking as major threats facing Europe.
The EU system is composed of several institutions. Alongside 
the Member States, these institutions are tasked with 
designing and implementing different aspects of the EU’s 
comprehensive drug policies, through the priorities and 
actions set out in strategic planning documents. This paper 
looks at the EU institutions predominately involved in the 
management of drug supply reduction and internal security 
issues. In doing so, it elaborates the most relevant features of 
the institutional framework for addressing drug supply 
reduction and internal security issues, describing the policy 
actors involved in the policy process from planning to 
implementation. This includes the role of the European 
Parliament, the European Council, the Council of the European 
Union, the European Commission and the various committees 
and working groups that support their work. The paper also 
looks at the work of decentralised EU agencies, which 
undertake specialist roles, frequently of a technical or 
scientific nature. The work of a number of these agencies 
contributes to the development and implementation of 
strategic policy tools, such as drug strategies and action plans 
of EU drug supply reduction and internal security policies 
through, for example, the provision of analytic support.
The EU’s legislation has been built over many years through 
the provisions made in different treaties and the instruments 
that have been adopted to implement them. This system 
forms the basis for cooperation among Member States and 
between the EU and the rest of the world. The production and 
trafficking of illicit drugs are inextricably linked to cross-border 
organised crime, as the raw materials to manufacture them, 
the equipment used, the substances themselves and the 
profits gained move between different legal jurisdictions. 
Appropriate responses and tools are needed to tackle the 
security and other challenges that the operation of illicit 
supply chains present. This paper takes a look at some of the 
most relevant treaties and legislations that provide a means to 
target the supply of illicit drugs, as well as the instruments and 
programmes that support this action.
In responding to the interlinked set of problems posed by the 
production and trafficking of illicit drugs within and outside the 
EU, the European Commission operates several funding 
instruments and programmes in conjunction with their EU and 
I Summary
The production and trafficking of illicit drugs poses a set of 
complex and interlinked problems, which have a negative 
impact on public health and the security and stability of 
society. With an illicit drug market worth billions of euros, 
many of Europe’s organised crime groups are involved in this 
trade. Some drugs are cultivated, produced and trafficked 
from other regions into Europe (cannabis resin, cocaine, 
heroin, new psychoactive substances), whereas others are 
manufactured and distributed within Europe and from there to 
other areas (amphetamine, ecstasy, herbal cannabis). 
European industries, logistical supply chains and the financial 
infrastructure underpinning the legal economy can be 
penetrated and used by traffickers to produce, transport and 
profit from illicit drugs. Chemical substances with legitimate 
industrial applications may be diverted from the licit trade and 
used to manufacture illicit drugs. Substances that are 
frequently subject to diversion are called drug precursors. The 
air, sea, road and rail networks for passengers and freight are 
exploited to ship drugs, creating border management 
challenges. The proceeds of crime are laundered through 
legitimate businesses where they can infiltrate the economy, 
providing criminals with the financial means to sustain the 
drug trade and fund other illegal activities. Accordingly, 
actions aimed at reducing the flow of illicit drugs and curbing 
the activities of organised crime groups must address 
developments taking place inside and outside the EU 
simultaneously. 
In responding to the dynamics of a globalised drug market, the 
EU and its partners are involved in actions at the international, 
regional, national and local levels. The present paper focuses 
primarily on actions at the EU level directed at the Union’s 
internal security situation. A wide range of EU-level policy 
actors participate in the response to drug supply and security 
challenges. This paper looks at the way aspects of the different 
agendas and missions of these EU bodies, insofar as they are 
related to drug supply reduction and internal security issues, 
work together to implement policy objectives and strategic 
actions. Across three sections, the paper elaborates who is 
involved in setting policy, what legal and funding basis for 
action has been established, and what the main priorities are.
The drug supply reduction and internal security measures 
discussed in this paper originate in EU-level strategic planning 
documents. These include the Stockholm Programme, the EU 
internal security strategy, the EU policy cycle for organised 
and serious international crime and the EU drugs strategy 
2013–20 and action plan 2013–16. 
Drug supply reduction can be defined as the set of activities 
undertaken by the EU and its Member States to restrict the 
availability of illicit drugs. This encompasses legal measures 
and operational cooperation in policing and border control 
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I Introduction
The production and trafficking of illicit drugs poses a set of 
complex and interlinked problems, which have a negative 
impact on public health and the security and stability of 
society. With an illicit drug market worth billions of euros, 
many of Europe’s organised crime groups are involved in this 
trade (Europol, 2013). Some drugs are cultivated, produced 
and trafficked from other regions into Europe (cannabis resin, 
cocaine, heroin, new psychoactive substances), whereas 
others are manufactured and distributed within Europe and 
from there to other areas (amphetamine, ecstasy, herbal 
cannabis) (EMCDDA, 2013a; EMCDDA and Europol, 2013). 
Logistical supply chains and the financial infrastructure 
underpinning the legal economy can be penetrated and used 
by criminals to produce, transport and profit from illicit drugs. 
Chemical substances with legitimate industrial applications 
may be diverted from the licit trade and used to manufacture 
illicit drugs. Substances that are frequently diverted in this 
way are called drug precursors. The air, sea, road and rail 
networks for passengers and freight are exploited to ship 
drugs, creating border management challenges. The proceeds 
of crime are laundered through legitimate businesses, where 
they can infiltrate the economy, providing criminals with the 
financial means to sustain the drug trade and fund other illegal 
activities.
Accordingly, actions aimed at reducing the flow of illicit drugs 
and curbing the activities of organised crime groups must 
address developments taking place inside and outside the 
European Union (EU) simultaneously. This approach reflects 
the dynamics of a globalised drug market, characterised by 
multiple shipment methods and routes, along which 
commodities move, undermining the rule of law, generating 
public health problems and threatening the stability of states 
in the process (see the box ‘Drug supply reduction and 
security challenges’). 
Given the size and global nature of this market, the EU and its 
partners are involved in a large number of actions at the 
international, regional, national and local levels. In this report, 
the focus is primarily on actions at the EU level directed at the 
Union’s internal security situation (1) (see the box ‘Defining 
drug supply reduction and internal security’). These measures 
originate in the Stockholm Programme, the EU internal 
security strategy, the EU policy cycle for organised and 
serious international crime and the EU drugs strategy 2013–
20 and action plan 2013–16 (Council of the European Union, 
2010b, 2012d, 2013e; European Council, 2010a, 2010b). 
(1)  Actions addressing the external dimensions of EU drug and security policies 
and the international partners they are undertaken with are the focus of a 
companion report scheduled for publication in 2014.
international partners to support drug supply reduction 
activities. The paper discusses the four categories into which 
these financial instruments and programmes fall. These 
consist of framework programmes (e.g. Security and 
Safeguarding Liberties), programmes for EU candidate and 
potential candidate countries (e.g. Instrument for Pre-
accession Assistance), geographic or regional programmes 
(e.g. European Neighbourhood Policy) and specific 
programmes that complement geographic ones (e.g. 
Instrument for Stability). Funding for these tools is provided 
through the EU’s overall budget and, in some cases, in 
cooperation with consortiums of Member States and the EU’s 
international partners. 
Given the complex and far-reaching nature of the problems 
posed by the production and trafficking of illicit drugs, 
responses to these issues span several areas of policy. The 
general approach taken by the EU in response to these 
problems is elaborated in the EU’s internal and external 
security and drug policies. Both of these policy fields have a 
comprehensive scope, extending beyond drug supply 
reduction. The EU internal security policy is concerned with 
terrorism, cybercrime, the activities of organised crime groups, 
trafficking in human beings and the production and supply of 
illicit drugs. Structurally, the EU drug strategies have been 
built around two pillars — demand and supply reduction 
— and three cross-cutting, or transversal, themes — 
coordination, international cooperation, and information, 
research, monitoring and evaluation, an approach now also 
present in the drugs strategies of most EU Member States. 
Consequently, EU-level drug supply reduction policy forms 
part of these two overarching areas, which complement and 
support each other, where concerns around the illicit drugs 
trade are increasingly situated within the overall context of 
internal and external security challenges. It is predominantly 
these two areas that provide the framework for action against 
the production and trafficking of drugs, where measures 
agreed and designed by the Member States and the EU 
institutions are elaborated, providing the agenda for action 
undertaken with the legal and funding tools at their disposal. 
This paper looks at how drug supply reduction arises in both 
policy areas and sets out the type of actions being taken. 
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The EU institutions and agencies play an important role in 
contributing to the development and maintenance of a 
knowledge base for policy-making in the field of drugs. As the 
means of producing and trafficking drugs evolves to overcome 
existing enforcement measures, monitoring and intelligence-
led operations provide the means for the EU to keep pace with 
and counter the illicit drug trade. A wide range of EU-level 
policy actors participate in the response to drug supply and 
security challenges. This report focuses on the way aspects of 
the different agendas and missions of these EU bodies, insofar 
as they are related to drug supply reduction and internal 
security issues, work together to implement policy objectives 
and strategic actions.
The present report responds to the emphasis on policy 
analysis and evaluation in the EU’s approach to drug and 
In 2013, the EMCDDA and Europol published the ‘EU 
drug markets report — a strategic analysis‘, providing a 
comprehensive overview of the production, consumption 
and trafficking of illicit drugs in Europe. It provided 
important insights into the operation of the drug market:
–  there is an increased level of interaction between the 
markets for heroin, cocaine, cannabis and synthetic 
drugs;
–  drug trafficking is becoming more diversified, with 
multiple transit points and complex channels and the 
increased use of legitimate commercial transport;
–  organised crime groups adopt a multi-commodity 
approach, engaging in a range of illicit activities;
–  globalisation plays an important role in the changing 
nature of the drug market, affecting the flow, 
availability and demand for drugs; 
–  the Internet is playing an increased role in facilitating 
the marketplace for drugs and providing access to 
knowledge, expertise and logistics; 
–  the increased demand for drugs in Africa, Asia and 
Latin America has had impacts on the flow of drugs to 
and from Europe;
–  the EU is a producer of synthetic drugs and cannabis 
and a source for heroin precursors (acetic anhydride); 
–  technological advances are changing the production 
of drugs, resulting in the use of non-controlled 
chemicals (including pre-precursors) and the 
manufacture and marketing of new psychoactive 
substances;
–  the significance of heroin is changing; although it 
remains an important drug, signs of a long-term 
decline are present;
–  consumers of illicit drugs are less discerning in their 
choice of substance, with users substituting one drug 
for another or using multiple drugs, particularly in the 
case of stimulants;
–  unregulated new substances (e.g. synthetic 
cannabinoid receptor agonists, cathinones) and 
controlled drugs that were not widely used before (e.g. 
ketamine, methamphetamine) are increasing in 
importance;
–  there is a high demand for cannabis, with a diversity of 
products, producers and sources, alongside increased 
domestic production. 
Source: EMCDDA and Europol (2013).
Drug supply reduction and security 
challenges
A hallmark of the EU is the area of freedom, justice and 
security that has been created with the removal of 
internal border controls in the Schengen Area, where 
citizens can enjoy the benefits of unrestricted freedom of 
movement between European countries. These same 
factors have given rise to a set of challenges posed by 
the illicit drug market and its impact on the security of 
the EU. 
Drug supply reduction can be defined as the set of 
activities undertaken by the EU and its Member States to 
restrict the availability of illicit drugs. This encompasses 
legal measures and operational cooperation in policing 
and border control aimed at detecting and disrupting the 
cultivation, production, shipment, distribution and sale of 
illicit drugs and the profits derived from these activities, 
both inside and outside the EU. In maintaining an area of 
freedom, justice and security, characterised by respect 
for human rights, the rule of law and solidarity, the EU 
works on two fronts simultaneously: externally, with its 
immediate neighbours and international partners, and 
internally, with its own Member States. Internal security 
issues can be defined as problems that threaten to 
undermine the EU’s stability and the health and safety of 
its citizens through, among other things, the operation of 
supply routes for illicit commodities (e.g. drugs) and illicit 
markets for their sale. The EU internal security strategy 
defines organised and serious crime and drug trafficking 
as major threats facing Europe (European Council, 
2010a).
Defining drug supply reduction and internal 
security
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I Institutional arrangements
The European Union’s system consists of several 
institutions (2). Alongside the Member States, these 
institutions are tasked with designing and implementing 
different aspects of the EU’s comprehensive drug policies 
through the different priorities and actions set out in strategic 
planning documents. This section looks at the EU institutions 
that are predominately involved in the management of drug 
supply reduction and internal security issues. In doing so, it 
elaborates the most relevant features of the institutional 
framework for addressing drug supply reduction and internal 
security issues, describing the policy actors involved in the 
policy process from planning to implementation.
I European Parliament
The European Parliament’s functions include passing laws, in 
conjunction with the Council of the European Union, through 
the ordinary legislative procedure (formerly ‘co-decision’) that 
applies to many areas of EU law, approving the EU budget and 
discussing EU policies (European Parliament, 2013b). Drug 
issues arise in different areas of the Parliament’s work when, 
for example, it considers internal security matters or relations 
with non-EU countries (‘third countries’). Consequently, 
various parliamentary standing committees are engaged with 
these policy areas, such as the Foreign Affairs Committee 
(AFET), the Security and Defence Committee (SEDE), the 
Civil Liberties, Justice and Home Affairs Committee (LIBE), or 
its Special Committee on Organised Crime, Corruption and 
Money Laundering (CRIM) (European Parliament, 2013a). The 
Standing Committee on Operational Cooperation on Internal 
Security (COSI), attached to the Council of the European 
Union, which plays a key role in internal security matters, is 
required to report to the Parliament and keep it informed 
about its work (Council of the European Union, 2009b).
I European Council
The European Council is tasked with setting the general 
political directions and priorities of the EU. This body, which 
meets at least four times a year, has addressed drug supply 
reduction and organised crime issues in the context of its 
work on the EU’s security situation (European Council, 2013). 
In 2003, it adopted the (external) European security strategy 
‘A secure Europe in a better world’. In the Stockholm 
Programme, in 2010, the European Council called on the 
Council of the European Union and the European Commission 
to develop an internal security strategy for the EU, which it 
(2)  The European Parliament, the European Council, the Council of the European 
Union (‘the Council’), the European Commission, the Court of Justice of the 
European Union, the European Central Bank and the European Court of 
Auditors.
security issues generally, and the need for an analysis of 
supply reduction policies expressed in the EU drugs strategy 
2013–20 (priority 22.10, Council of the European Union, 
2012d). It also contributes to the development of an overview 
of the EU policy cycle for organised and serious international 
crime, requested by the European Commission in its mid-term 
evaluation of the policy cycle (finding 5b, Council of the 
European Union, 2013a). In this respect, it situates this 
specific organised crime policy and the EU’s drugs policy 
within the overarching security policy framework that defines 
the scope and actions of these implementing and coordination 
oriented strategic tools. The report provides a clear and 
comprehensive introduction to EU-level action that will assist 
those working in the area nationally, provide researchers with 
orienting information on the mechanisms and direction of 
activities and the public with an insight into the Union’s work 
in this field. 
This report is designed to be accessible for readers, with each 
section presenting a stand-alone guide to the areas 
addressed as they relate to drug supply reduction. The 
different sections of the report elaborate the policy process 
regarding who is involved in setting policy, what legal and 
funding basis for action has been established, and what the 
main priorities are. In this way, the report can be read in its 
entirety or used as a reference point for each area 
individually. Specifically, the report is divided into three 
sections, addressing first the institutional arrangements, then 
the relevant legislation and funding tools to facilitate action, 
and finally the policy framework that guides activities. 
Throughout the document, tables provide quick access to 
developments and processes, and the EU abbreviations 
commonly used in this field are explained at the end of the 
report. A comprehensive set of references is provided, most 
of which are available online, should readers wish to explore 
further the areas covered.
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Table 1 highlights the working parties, and their associated 
Council configurations, where drug supply reduction and 
internal security issues commonly arise. A distinction is made 
between the general working groups and the top-level 
committees, Coreper I and II, where the Member States are 
represented. This reflects the vertical decision-making chain 
along which information passes, for example, from COSI to 
the Antici Group and on to Coreper II, before reaching the JHA 
Council. At all stages, representatives of the Member States 
drive the process. 
Defined in article 240 of the Lisbon Treaty (TEU), the 
Permanent Representatives Committee (Coreper) is 
responsible for preparing the work of the Council. All 
information related to decision-making passes through 
Coreper, and it functions both as a communication 
mechanism between Member States and a supervisory 
structure for the Council’s various working groups. Coreper is 
tasked with reviewing the European Commission’s legislative 
proposals and coming to an agreement prior to passing the 
relevant dossier up to the Council. Accordingly, Coreper works 
across the full spectrum of policy concerns, which it 
addresses by operating in two configurations focused on 
different areas. Coreper I consists of the Member States’ 
deputy permanent representatives, and their work is 
supported by the preparatory body the Mertens Group. The 
Member States’ permanent representatives meet in Coreper 
II, and are assisted by their own support structure, the Antici 
Group. Justice and Home Affairs (JHA) issues, where drug 
supply reduction and internal security matters generally 
feature, arise in the work of Coreper II. The Council’s working 
groups, such as COSI and the HDG, report to Coreper 
(European Commission, 2012d). 
endorsed in March 2010 (European Council, 2003, 2010a, 
2010b). In this way, it has played an important role in defining 
EU security policies along the spectrum of concerns that the 
Union faces outside and inside its borders. 
I Council of the European Union
Alongside the European Parliament, the Council of the 
European Union is one of the main decision-making bodies of 
the EU. The Council performs a diverse set of functions, 
including adopting legislation (often in conjunction with the 
European Parliament), playing a policy coordination role for 
the Member States, devising the EU Common Foreign and 
Security Policy (CFSP), signing off on agreements between 
the EU and third countries, and adopting the EU’s annual 
budget (Council of the European Union, 2013g). 
The Council is one of the EU institutions in which drug supply 
reduction and internal security matters arise most frequently. 
In common with national administrations, the Council uses a 
system of working parties to address the array of policy areas 
with which it must deal. The working parties operate under the 
different Council configurations and under the Permanent 
Representatives Committee (Coreper) and its preparatory 
support bodies (the Mertens and Antici groups). As part of the 
rotating, bi-annual presidency of the Council, each Member 
State takes a turn in chairing these working parties. Whereas 
drug supply reduction and security issues arise in the work of 
several Council working groups, two are particularly important 
in this policy area: the Standing Committee on Operational 
Cooperation on Internal Security (COSI) and the Horizontal 
Working Party on Drugs (HDG).
TABLE 1
Council configurations, committees and working groups
Council configurations
Agriculture and Fisheries (AGRI) Environment (ENVI)
Competitiveness (COMPET) Foreign Affairs (FAC)
Economic and Financial Affairs (ECOFIN) General Affairs (GAC)
Education, youth, culture and sport (EYCS) Justice and Home Affairs (JHA)
Employment, Social Policy, Health and Consumer Affairs (EPSCO) Transport, Telecommunications and Energy (TTE)
Committees
Deputy Permanent Representatives Committee 
(Coreper I)
Competencies: AGRI, COMPET, EPSCO, ENVI, 
EYCS and TTE
Preparatory body: Mertens Group
Permanent Representatives Committee 
(Coreper II)
Competencies: ECOFIN, FAC, GAC and JHA
Preparatory body: Antici Group
Political and Security Committee (PSC)
Competencies: CFSP and CSDP
Working parties
Standing Committee on Operational Cooperation on Internal Security (COSI) Related configuration: JHA
Customs Cooperation Working Party (CCWP) Related configuration: JHA
Coordinating Committee in the area of police and judicial cooperation in criminal matters (CATS) Related configuration: JHA
Horizontal Working Party on Drugs (HDG) Related configuration: GAC
Working Party on Customs Union (CUG) Related configuration: COMPET
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of the EU drugs strategy and action plan. In this respect, the 
HDG functions as a mechanism through which all of the 
Member States can participate in the formulation of the EU 
drugs strategies and action plans. The working party also 
plays an important role in the EU’s drug policy oriented 
relations and dialogues with non-EU countries.
Drug supply reduction and security issues can feature in the 
work of many other Council working groups, but are not their 
primary concerns. Examples of these include groups with a 
wider purview of policing, such as the Coordinating 
Committee in the area of police and judicial cooperation in 
criminal matters (CATS) (‘Article 36 Committee’) and the Law 
Enforcement Working Party (LEWP). Similarly, issues dealt 
with by working groups handling customs matters, such as the 
movement of passengers and cargo via air and sea routes, can 
be relevant to drug supply reduction. Among these groups are 
the Customs Cooperation Working Party (CCWP), the Working 
Party on Customs Union (CUG), the Working Party on 
Shipping and the Working Party on Aviation. 
I European Commission
Within the EU’s institutional framework, the European 
Commission has a wide range of functions. It has the right of 
initiative to propose new legislation, and is responsible for 
ensuring that the Member States are correctly implementing 
the Union’s laws. Alongside drafting the EU’s annual budget and 
overseeing how the funds are being used, it is also responsible 
for undertaking international negotiations on behalf of the EU 
(European Commission, 2013c). Structurally, the Commission 
consists of 33 departments referred to as Directorates-General 
(DGs). Drug supply reduction and security issues arise in 
different areas of the Commission’s work. 
The Commission is responsible for managing the EU’s internal 
security policy, the Union’s migration and asylum policy, the 
financing of activities in the home affairs area and the external 
aspects of this policy field. It manages a set of policies and 
programmes in the internal security area and is responsible 
for a number of specialised EU agencies in this field. Its work 
on internal security covers the fight against organised crime, 
which encompasses drug supply reduction issues, as well as 
fostering cooperation among police forces and managing the 
EU’s external borders (European Commission, 2013h). 
Among its responsibilities, the Commission is tasked with 
ensuring that the EU is an area characterised by justice, where 
the fundamental rights of citizens are respected, people receive 
equal treatment, their personal data is protected and there is 
access to support in legal matters throughout the EU. The 
Commission addresses drug control policy in a broad sense, 
and covers a range of issues under drug demand reduction and 
drug supply reduction. These include the monitoring and 
Established under the Lisbon Treaty (article 71, TFEU) by a 
Council decision, COSI plays an important role in coordinating 
the European Union’s response to drug supply and internal 
security issues (Council of the European Union, 2009b). It 
operates under the JHA configuration of the Council, and is 
one of only three working parties created by an EU Treaty 
(Council of the European Union, 2013f), the others being 
Coreper and the PSC (Political and Security Committee). The 
need for a standing committee in this area arose from the way 
the Lisbon Treaty (TFEU) altered the EU’s legal framework. 
The treaty resulted in the so-called ‘three pillars’ (the 
European Community, the Common Foreign and Security 
Policy (CFSP), and police and judicial cooperation in criminal 
matters) being abolished and replaced by the European Union, 
endowed with legislative procedures for its competences 
(European Commission, 2010c). 
COSI, which consists of the Member States’ representatives, 
was mandated to facilitate better operational cooperation 
among the Member States’ competent authorities in internal 
security matters, and to evaluate these activities. It was also 
tasked with assisting the Council, reporting to the Parliament, 
but is not involved in carrying out operational activities (the 
responsibility of Member States) or preparing legislation 
(Council of the European Union, 2009b). Article 222 of the 
Lisbon Treaty (TFEU), the ‘solidarity clause’, requires COSI 
and the PSC to support the Council in responding to disasters 
(i.e. terrorist attacks, natural or man-made disasters) within 
the EU (Council of the European Union, 2009c). In the 
Stockholm Programme, which addresses the EU’s priorities 
for the area of freedom, justice and security until 2014, 
responsibility for the implementation of the EU internal 
security strategy was placed under COSI (Council of the 
European Union, 2010a). The standing committee plays a 
leading role in defining, implementing, monitoring and 
evaluating the EU’s activities in the policy cycle for organised 
and serious international crime (Council of the European 
Union, 2010b).
With a broader drug policy remit than that of COSI, the HDG 
operates under the General Affairs configuration of the 
Council. Reflecting the view that one working party should 
function as a point to centralise knowledge about the full array 
of internal and external EU drug policy activities taking place, 
the HDG’s purview encompasses all areas of drug demand 
reduction and drug supply reduction (Council of the European 
Union, 1999). Within the Council, it is the main working party 
through which all drug policy matters are considered, before 
being passed up to Coreper and on to the JHA Council, where 
final decision-making takes place. The HDG plays a central 
role in the development and adoption of the EU drugs 
strategies and action plans, and is chaired for a period of six 
months by the Member State that holds the presidency of the 
Council. During this time, the chair is responsible for driving 
the work of the HDG forward and ensuring the implementation 
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conducting the EU’s CFSP, developing policy proposals and 
chairing the Foreign Affairs configuration of the Council. 
Assisting the High Representative, the EEAS is tasked with 
developing policy proposals and implementing them after 
approval is received from the Parliament and the Council 
(European External Action Service, 2013). The EEAS is an EU 
body. It oversees the EU delegations in more than 130 
countries, coordinates the EU’s external action, and is the 
permanent chair of the Council’s Political and Security 
Committee (PSC), which is responsible for the CFSP. The 
EEAS also carries out the strategic programming for EU 
external assistance, which is then implemented by 
EuropeAid. 
Given the overlap between external and internal matters on 
the spectrum of security issues facing the EU, the different EU 
bodies involved work together to ensure consistency in the 
approach taken and synergies across activities. The EEAS and 
the PSC, which work on the (external) European security 
strategy, regularly meet with COSI in implementing the 
internal security strategy. In this way, relevant information is 
passed between those dealing with the internal and external 
security matters. The EEAS’s Intelligence Analysis Centre (EU 
INTCEN, formerly SITCEN) provides situational analysis on 
issues relevant to drug supply reduction. An example of such 
an issue is the challenges faced by police liaison officers in the 
Sahel and Maghreb as a result of terrorism threats and state 
destabilisation. The European Commission’s Service for 
Foreign Policy Instruments (FPI) operates under the authority 
of the High Representative in her capacity as Vice President of 
the European Commission. It implements the short-term crisis 
response components of the Instrument for Stability (IfS), 
through which anti-drug trafficking programmes such as the 
Cocaine Routes Programme and the Heroin Routes 
Programme are financed.
Figure 1 shows the different structures in the EU system 
related to drug supply reduction. This includes EU institutions 
(the European Council, the Parliament, the Council and the 
Commission), EU bodies (the EEAS), coordination platforms 
(EMPACT), the EU Member States and the EU’s decentralised 
agencies.
Different processes are involved at various levels in this 
system. These include collecting data and turning it into 
policy-relevant information that can be used as a basis for 
decision-making, the process of proposing, approving, 
implementing and monitoring legislation, the coordination of 
operational actions, and the setting of top-level priorities. 
Throughout these practices, the representatives of all Member 
States play a key role. 
evaluation of EU Member States’ measures directed at the 
reduction of drug use and the prevention of drug-related crime 
and drug trafficking. It proposes measures for the control of 
new psychoactive substances, based on risk assessment 
procedures, and ensures the implementation of EU laws 
designed to prohibit the use of chemicals to produce illicit 
drugs. In addition, the Commission promotes European 
cooperation in addressing drug problems, through the provision 
of financial assistance (European Commission, 2013b). 
Licit trade in chemical substances with industrial applications 
is monitored and controlled by the EU through a set of 
dedicated pieces of legislation (see the next section). Different 
aspects of this control framework are managed by the 
Commission. There are two regulations, one of which relates 
to the trade between Member States in chemical substances 
with industrial applications, whereas the other concerns the 
external trade in these substances between the EU and third 
countries. These pieces of legislation aim to prevent the 
diversion of drug precursors from legal trade into the illicit 
drug manufacturing market. 
Issues that may affect the stability of the EU’s immediate 
geographical neighbours and its international partners also 
have an effect on the Union’s internal security as a result of 
the globalised nature of the illicit drugs trade and the 
problems it causes. The Commission addresses these matters 
through a number of its activities. It is tasked with planning 
development policies, programmes and projects, through 
which it provides aid in different countries. It has financed two 
programmes in Central Asia that support the EU’s drug policy 
activities: the Border Management Programme in Central Asia 
(BOMCA) and the Central Asia Drug Action Programme 
(CADAP). BOMCA, an important anti-drug trafficking initiative, 
is aimed at the development and use of modern border 
management methods in the region, and has been supported 
between 2003 and 2014 by budgets totalling EUR 33 million. 
The main aim of CADAP is to promote a balanced approach to 
drug policy, whereby drug supply reduction and demand 
reduction elements are given an equal focus and established 
best practices are adopted. Between 2001 and 2013 the 
programme’s budgets totalled EUR 5 million (European 
Commission, 2012a).
In addressing the EU’s capacity to deal with external action, 
the Lisbon Treaty called for the establishment of the post of 
High Representative of the Union for Foreign Affairs and 
Security Policy (TEU article 15) and the European External 
Action Service (EEAS, TEU article 27) (Council of the 
European Union, 2012b). The High Representative is in charge 
of the EEAS and is responsible for, among other things, 
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I Decentralised agencies
Decentralised agencies of the EU undertake specialist roles in 
key areas, often tasks of a technical or scientific nature. A 
number of these agencies contribute to the development and 
delivery of EU drug supply reduction and internal security 
policies, playing an important role in the work of the EU 
institutions and various expert working groups. They provide 
analytical support in the development and implementation of 
strategic policy tools, such as drug strategies and action plans.
Countering the production and trafficking of illicit drugs 
requires information on the organised crime groups involved, 
the scale of the market, the types of substances being 
manufactured and the routes involved in distributing them. 
Although work is underway to improve the information on drug 
production and trafficking, through the construction of supply 
reduction indicators, there is a lack of data on the illicit 
markets for drugs. The European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA) is tasked with providing the EU 
and its Member States with factual, objective, reliable and 
comparable information at European level concerning drugs 
and drug addiction and their consequences (EMCDDA, 2010). 
As part of this work, it collects data from its Reitox national 
focal points on a range of drug supply reduction and demand 
reduction issues. This includes information about drug law 
offences, drug seizures, drug purity and potency, as well as 
retail prices for drugs (EMCDDA and Europol, 2013). It also 
operates the Early warning system (EWS) on new 
psychoactive substances in conjunction with Europol, the 
European Police Office, and conducts risk assessments. The 
Centre participates in the operational action plans that 
implement the EU policy cycle on organised and serious 
international crime (hereinafter ‘policy cycle’; see the section 
‘Policy cycle on organised and serious international crime’). 
Europol is responsible for helping to make the EU a safe society 
for its citizens, and has a wide range of functions in its mission 
to assist Member States to respond to serious and organised 
international crime. In the drugs supply reduction area, Europol 
provides intelligence information, collects data and runs 
information systems on the activities of organised crime 
groups, the substances they manufacture, the locations and 
equipment they use and their smuggling and transportation 
methods. It carries out threat assessments in different regions 
and produces the Serious and Organised Crime Threat 
Assessment (SOCTA) and the EU Terrorism Situation and Trend 
Report (TE-SAT), which inform policy-making and planning 
processes, such as the EU policy cycle. It works closely with the 
Member States through its Europol national units, and 
functions as a specialist information hub, supporting policing 
operations throughout the EU. At Europol, the Operations 
Department also houses the Europol Criminal Assets Bureau 
and the Europol Cyber Crime Centre. Europol also provides 
secretariat services for the Camden Asset Recovery Inter-
Agency Network (CARIN). In doing so, it supports the EU 
internal security strategy’s aim to target the proceeds of crime 
at all stages from seizure to forfeiture (Europol, 2012). It also 
plays a central role in facilitating action under the EU policy 
cycle through its specialised information services and the 
support it provides for the European Multidisciplinary Platform 
against Criminal Threats (EMPACT), through which coordinated 
operational actions are implemented (see the section ‘Policy 
cycle on organised and serious international crime’). 
FIGURE 1
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Effective and integrated border management is a vital part of 
the response to drug trafficking and the security challenges it 
poses. The European Agency for the Management of 
Operational Cooperation at the External Borders of the 
Member States of the European Union (Frontex) plays an 
important role in this area. Drug supply reduction issues arise 
in several areas of its work. For example, it carries out joint 
operations at the EU’s external (air, land and sea) borders, 
provides training and undertakes risk analysis. It works with 
the EU’s international partners, such as the United Nations 
Office of Drugs and Crime (UNODC) and the Central Asia 
Border Security Initiative (CABSI). 
Cepol, the European Police College, is involved in building 
police cooperation across the EU. It provides a wide range of 
training courses relevant to different aspects of supply 
reduction and internal security activities. In conjunction with 
Europol, it provides training to national law enforcement 
officers on the dismantling of clandestine laboratories used to 
manufacture illicit drugs. Cepol also facilitates the 
implementation of the EU policy cycle through the provision of 
specialised training workshops on the development of 
strategic plans and projects. It works closely with police 
training colleges in the Member States to deliver different 
training courses (Cepol, 2013). 
Eurojust is the European Union’s judicial cooperation unit, and 
is primarily aimed at developing the coordination of cross-
border investigations and prosecutions, as well as creating 
better cooperation among the Member States’ judicial 
authorities. Among the issues covered in its work are the 
activities of organised crime groups, such as drug trafficking 
and money laundering. It provides assistance to Member 
States when requested to do so and when it is enabled by the 
presence of a cooperation agreement. Eurojust can request 
Member States to investigate or prosecute a crime, to work 
together and to establish a joint investigation team (see the 
next section). It works closely with the European Judicial 
Network and Europol, and assists national authorities with the 
use of mutual legal assistance and the use of mutual 
recognition legal tools, such as the European arrest warrant, 
supporting the EU policy cycle in the process. In addition, it 
works with Member States on the use and coordination of 
controlled deliveries of illicit drugs (Eurojust, 2013b, 2013c). 
Eurojust provides statistics on the cases against drug 
trafficking that it has supported each year in its annual reports 
(Eurojust, 2013a). 
The following section of this report explores EU legislation 
related to supply reduction issues, and looks at some of the 
main legal tools used in the fight against the production and 
trafficking of illicit drugs. 
I Legislation and financial programmes 
The EU’s legislation has been built up over many years through 
the provisions made in different treaties and the instruments 
that have been adopted to implement them. This system 
forms the basis for cooperation among Member States and 
between the EU and the rest of the world. The production and 
trafficking of illicit drugs are inextricably linked to cross-border 
organised crime, as the raw materials to manufacture them, 
the equipment used, the substances themselves and the 
profits gained move between different legal jurisdictions as 
they are shipped to drug markets. Appropriate responses and 
tools are needed to tackle the security and other challenges 
that the operation of illicit supply chains present. This section 
of the report looks at some of the most relevant treaties and 
legislation that provide a means to target the supply of illicit 
drugs, as well as the instruments and programmes that 
support this action. The policy priorities that these measures 
relate to are the subject of the next section. 
I Legal frameworks for planning and cooperation
The EU’s laws take a number of forms, and this subsection 
sets out some of the main legal instruments related to drug 
supply reduction and internal security measures. Three 
institutions play a central role in the development and 
adoption of EU legislation: the European Parliament, the 
Council of the European Union and the European Commission. 
In terms of general process, the Commission makes proposals 
for new pieces of legislation. These are considered and, if 
approved, adopted by the European Parliament and the 
Council of the European Union (the Council). Both of these 
institutions have the same decision-making power on many 
issues through the ‘ordinary legislative procedure‘ (formerly 
‘co-decision’). Alongside making proposals, the Commission is 
responsible for checking that Member States are correctly 
applying and implementing EU legislation. EU-level treaties 
and legislative instruments are developed in line with the 
principles of subsidiarity and proportionality, which ensure 
that EU legal measures are necessary and take an appropriate 
form (see the box ‘Subsidiarity and proportionality’). 
The Lisbon Treaty modified the structure of the EU’s 
institutions, revised the way in which decision-making works, 
strengthened European democracy, and changed the Union’s 
internal and external policies (European Commission, 2010d). 
Among the reforms that it ushered in were changes in the 
operation of the Justice and Home Affairs (JHA) area, which 
encompasses the EU’s response to drug supply and internal 
security issues. In the past, the EU was based around the 
so-called three-pillar model, which was: (1) the European 
Community, (2) the Common Foreign and Security Policy 
(CFSP) and (3) police and judicial cooperation in criminal 
matters (where drug supply reduction issues most commonly 
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arise). This system was burdened by complex processes, as 
issues in the first pillar were subject to the EU’s legislative 
procedures, whereas matters in the second and third pillars 
were addressed mostly, but not exclusively, through 
intergovernmental cooperation. The Lisbon Treaty removed 
the pillar structure, and introduced three types of 
competence: (1) exclusive competences (where only the EU 
can legislate), (2) shared competences (where the EU and the 
Member States can legislate) and (3) supporting 
competences (where the EU cannot legislate, but can support 
Member States’ activities) (European Commission, 2010c). 
As a result of the Lisbon Treaty, JHA matters are now subject 
to the same legislative procedures as other areas (‘ordinary 
legislative procedure’), and are not addressed through 
intergovernmental cooperation, giving the European 
institutions increased scope for legislative action. This 
concerns matters at the heart of drug supply reduction and 
internal security, such as border control, judicial cooperation 
in criminal matters and police cooperation (European 
Commission, 2010a). These areas were addressed under Title 
V of the Lisbon Treaty, which is concerned with the EU’s area 
of freedom, security and justice. For example, in these articles, 
provision was made for the creation of the Standing 
Committee on Operational Cooperation on Internal Security 
(COSI) and updating the scope of Europol and Eurojust’s 
missions. Some of the most relevant articles of the Lisbon 
Treaty, and the aspects of drug supply reduction and internal 
security that they related to are presented in Table 2. 
In understanding how the EU exercises its legal powers, 
articles 5(3) and 5(4) of the Treaty on European Union 
(TEU) are central, as they set out the principles of 
subsidiarity and proportionality, respectively (Council of 
the European Union, 2012b). Together, these two 
principles ensure that the EU must act only when there is 
a need for it to do so, and that the action it takes is 
appropriate. On the one hand, the subsidiarity principle 
holds that the EU should take action in order to meet its 
objectives when they can be best accomplished at the 
EU level, but not when these aims can be achieved 
through the individual actions of the Member States. On 
the other hand, the principle of proportionality is 
concerned with ensuring that the legal tools adopted are 
of an appropriate type with a suitable level of force. 
Accordingly, assessments are required to check that 
there are not other ways of reaching the same objective 
that are less restrictive. As Borchardt (2010) puts it, ‘The 
main conclusion to be reached in general terms is that 
framework legislation, minimum standards and mutual 
recognition of the Member States existing standards 




The Lisbon Treaty and drug supply reduction and internal security
Article Area covered
15 (TEU) High Representative of the Union for Foreign Affairs and Security Policy
27 (TEU) European External Action Service (EEAS)
38 (TEU) Common Foreign and Security Policy (CFSP)
67 (TFEU) The EU as an area of freedom, justice and security
68 (TFEU) Tasks the European Council with defining ‘the strategic guidelines for legislative and operational planning within the area of 
freedom, security and justice’
71 (TFEU) Standing Committee on Operational Cooperation on Internal Security (COSI)
77 (TFEU) Border control policy
82 (TFEU) Judicial cooperation in criminal matters
83 (TFEU) ‘Minimum rules concerning the definition of criminal offences and sanctions in the areas of particularly serious crime with a 
cross-border dimension’ (including illicit drug trafficking, money laundering and organised crime)
84 (TFEU) Crime prevention
85 (TFEU) Eurojust’s mission 
87 (TFEU) Police cooperation involving customs and specialised law enforcement services 
88 (TFEU) Europol’s mission
89 (TFEU) Provision for the creation of rules concerning the cross-border operation of Member States’ competent policing authorities in 
other Member States’ territories 
222 (TFEU) The ‘solidarity clause’ against acts of terrorism and COSI’s role in this context
NB: TEU, Treaty on European Union; TFEU, Treaty on the Functioning of the European Union; both treaties are amended by the Lisbon Treaty.






































































































NB: Not shown on the map are the island groups of the Azores and Madeira (Portugal) and the Canaries (Spain), all of which are within the Schengen Area.
Source: Redrawn and updated from European Commission (2012e).
Unrestricted freedom of movement is enabled within the EU by 
the abolition of internal border controls in the Schengen Area 
(Figure 2). The majority of EU Member States and a small 
number of non-EU countries are part of the Schengen Area. 
The production and trafficking of illicit drugs have been 
addressed in the development of the Schengen Area. Legally, 
the area is built upon the Schengen Agreement and Convention 
and a number of subsequent agreements, such as the 
Schengen Borders Code. Since 1999, these pieces of 
legislation have been part of the EU’s legal framework as a 
result of their being added as a protocol (‘the Schengen acquis’) 
to the Treaty of Amsterdam, currently protocol 19 of the Lisbon 
Treaty (TFEU). The Schengen Agreement and Convention 
reinforced checks at the EU’s external borders, set out 
procedures for issuing standardised visas and created the 
Schengen Information System. It also strengthened cooperation 
among police forces at the EU’s internal borders, and supported 
activities aimed at curbing drug trafficking (European 
Commission, 2009). Drug issues were addressed under Title III: 
Police and Security, Chapter 6 of the Schengen Agreement in 
several ways. For example, its articles covered issues such as 
the sale and import of drugs, external border checks, targeting 
the proceeds of crime and provision for controlled deliveries of 
drugs (Council of the European Union, 2000c). 
At a level below EU treaties, a set of legislative tools have been 
adopted, serving a number of purposes. For example, they 
provide the concrete means through which the Member 
States can work together to address cross-border criminal 
activities, such as illicit drug trafficking and production. They 
also function as the tools that underpin the achievement of 
the aims and actions in the EU’s internal security, drugs and 
policy cycle strategies. Collectively, these instruments 
facilitate collaboration and support among the Member States 
in addressing different aspects of the problems related to illicit 
drug markets. 
The legislation aims at discouraging and disrupting drug 
smuggling, bringing organised crime groups to justice and 
depriving them of the proceeds from their activities (Table 3). 
For example, the trade in drug precursors has been regulated 
to prevent diversion to illicit drug production. Furthermore, 
provision has been made for the movement of samples of 
controlled drugs during investigations (Council of the European 
Union, 2001, 2005d; European Parliament and the Council of 
the European Union, 2004). A response to the emergence of 
new psychoactive substances, involving a three-step process 
of information exchange, risk assessment and control has been 
implemented, resulting in EU-wide bans of certain drugs 
(Council of the European Union, 2005b, 2013c). 
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A range of legislation addressing crime in general are also 
relevant to the fight against drug trafficking. Building 
cooperation among the Member States’ police and customs 
authorities has been an important goal in successive EU-level 
treaties. Cooperation, both non-operational and operational, 
between the competent policing authorities in each Member 
State is dealt with in article 87 of the Lisbon Treaty (TFEU) 
(Council of the European Union, 2012b). The timely and 
efficient exchange of information to support policing lies at the 
core of cooperation between law enforcement agencies. A 
number of legal acts have been adopted to facilitate better 
flows of information between the competent authorities in the 
Member States. For example, the so-called Swedish Initiative, 
which replaced related articles in the Convention 
implementing the Schengen Agreement, ensures that the 
rules governing the exchange of information between Member 
States can be no more constraining than national-level 
standards (Council of the European Union, 2008a; European 
Commission, 2012g). The Prüm Decision made provision for 
the automated exchange of information (DNA, fingerprints, 
vehicle registrations) needed for criminal investigations and 
the participation of one Member State’s law enforcement 
personnel in joint operations in the territory of another 
Member State (Council of the European Union, 2006b; 
European Commission, 2013f). 
The processes involved in criminal investigations and judicial 
proceedings are supported by several legal acts. Legal 
provisions have been made for the use of controlled deliveries 
of drugs during investigations, the use of joint investigation 
teams, European arrest warrants and European evidence 
warrants, and agreement on the elements that comprise the 
TABLE 3
Legislation linked to drug supply reduction
Drug precursors
Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February 2004 on drug precursors
Council regulation (EC) No 111/2005 of 22 December 2004 laying down rules for the monitoring of trade between the Community and third 
countries in drug precursors
Council regulation (EC) No 1277/2005 of 27 July 2005 laying down implementing rules for Regulation (EC) No 273/2004 of the European Parliament 
and of the Council on drug precursors and for Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the 
Community and third countries in drug precursors
Risk assessment and control of new psychoactive substances
Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances
Council decision of 7 March 2013 on subjecting 4-methylamphetamine to control measures (2013/129/EU) (1)
Forensic analysis and criminal investigation
Council decision of 28 May 2001 on the transmission of samples of controlled substances (2001/419/JHA)
Council recommendation of 30 March 2004 regarding guidelines for taking samples of seized drugs (2004/C 86/04)
Information exchange
Council framework decision 2006/960/JHA of 18 December 2006 on simplifying the exchange of information and intelligence between law 
enforcement authorities of the Member States of the European Union (‘the Swedish initiative’)
Council decision 2008/615/JHA of 23 June 2008 on the stepping up of cross-border cooperation, particularly in combating terrorism and cross-
border crime (‘Prüm Decision’)
Judicial and police cooperation in criminal matters
Council Act of 29 May 2000 establishing in accordance with Article 34 of the Treaty on European Union the Convention on Mutual Assistance in 
Criminal Matters between the Member States of the European Union (2000/C 197/01)
Council framework decision of 13 June 2002 on joint investigation teams (2002/465/JHA)
Council framework decision of 13 June 2002 on the European arrest warrant and the surrender procedures between Member States (2002/584/JHA)
Council framework decision 2004/757/JHA of 25 October 2004 laying down minimum provisions on the constituent elements of criminal acts and 
penalties in the field of illicit drug trafficking
Council framework decision 2008/841/JHA of 24 October 2008 on the fight against organised crime
Council framework decision 2008/978/JHA of 18 December 2008 on the European evidence warrant for the purpose of obtaining objects, 
documents and data for use in proceedings in criminal matters
Proceeds of crime
Council Decision of 17 October 2000 concerning arrangements for cooperation between financial intelligence units of the Member States in respect 
of exchanging information
Council framework decision of 26 June 2001 on money laundering, the identification, tracing, freezing, seizing and confiscation of instrumentalities 
and the proceeds of crime (2001/500/JHA)
Council framework decision 2005/212/JHA of 24 February 2005 on confiscation of crime-related proceeds, instrumentalities and property
Directive 2005/60/EC of the European Parliament and of the Council of 26 October 2005 on the prevention of the use of the financial system for the 
purpose of money laundering and terrorist financing
Council Decision 2007/845/JHA of 6 December 2007 concerning cooperation between asset recovery offices of the Member States in the field of 
tracing and identification of proceeds from, or other property related to, crime
NB: Detailed overviews of EU anti-drug legislation can be accessed at the European Commission website under Home Affairs and Justice. 
(1) Similar legislation exists for a number of other substances; see Control measures on the EMCDDA website.
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criminal act of drug trafficking and its punishment (Council of 
the European Union, 2000a, 2002a, 2002b, 2004, 2008b). A 
basis exists from which Member States’ authorities can 
cooperate in targeting the proceeds of crime at all stages of 
their movement (identification, tracking, freezing, seizing and 
confiscation) and protect their financial systems (Council of 
the European Union, 2000b, 2001, 2005c). 
As the drugs situation evolves, so too does the EU’s response 
to it. Accordingly, the instruments used to target the illicit 
drugs industry are revised and updated to take account of new 
developments and to improve their practical application. The 
European Commission plays an important role here, as it 
reports on the implementation and functioning of European 
legislation and makes proposals for amendments or new 
pieces of legislation, following an impact assessment. For 
example, impact assessments have been made as part of 
considering the need to revise the regulations on drug control 
(Council of the European Union, 2012a).
I Financial programmes and instruments
Responding to the interlinked set of problems posed by the 
production and trafficking of illicit drugs requires action within 
and outside the EU, across a range of areas at the same time. 
Accordingly, several funding instruments and programmes, 
operated by the European Commission in conjunction with 
their EU and international partners, support drug supply 
reduction activities (Table 4). These instruments (3) fall into 
four categories: framework programmes (e.g. Security and 
Safeguarding Liberties), programmes for EU candidate and 
potential candidate countries (e.g. Instrument for Pre-
accession Assistance), geographic or regional programmes 
(e.g. European Neighbourhood Policy) and specific 
programmes that complement geographic ones (e.g. 
Instrument for Stability). Funding for these tools is provided 
(3)  Action directed outside the EU is discussed in a companion report addressing 
external security and drug supply reduction, scheduled for publication in 2014. 
through the EU’s overall budget and, in some cases, in 
cooperation with consortiums of Member States and the EU’s 
international partners. 
The ‘Internal security strategy for the European Union: towards 
a European security model’, adopted by the European Council 
in 2010, has set out the main parameters of the policy 
response to internal security challenges, including drug 
trafficking and production (European Council, 2010a). Its 
objectives are translated into action through, among other 
measures, the framework programme ‘Security and 
Safeguarding Liberties’, which fosters cooperation in 
combating crime. It funds a range of activities and provides 
financial support to the EU agencies Cepol, the EMCDDA and 
Europol. The framework programme is supported by two 
specific programmes of funding, one of which, ‘Prevention of 
and Fight against Crime’ (ISEC), is concerned with drug supply 
reduction issues (European Commission, 2013g). 
Established by a Council decision, the ISEC programme is 
scheduled to run between 2007 and 2013, with an overall 
budget of EUR 600 million (Council of the European Union, 
2007). The programme primarily funds projects through calls 
for proposals, which result in the awarding of action grants, 
with allocations totalling EUR 167 million by 2009. The ISEC 
programme is implemented on the basis of thematic annual 
work programmes, funding various activities, including 
training, equipment purchasing and supporting cross-border 
policing, such as joint investigation teams. These work 
programmes and the projects they fund support the priorities 
in EU policies, such as the EU internal security strategy, the 
policy cycle for organised and serious international crime, and 
the action plans of the Hague and Stockholm Programmes. 
For example, funding is grouped around issues underpinning 
work that will enhance the practical implementation of EU 
legislation that facilitates police cooperation and information 
exchange, such as the Prüm Decision and the Swedish 
Initiative (European Commission, 2011a, 2012b). 
The ISEC programme provides financial support to the 
Maritime Analysis Operations Centre — Narcotics (MAOC-N), 
which was established in 2007 to counteract drug trafficking 
from West Africa to Europe by sea and air via the Atlantic 
Ocean. It is an initiative between seven EU Member States 
(Ireland, Spain, France, Italy, Netherlands, Portugal, United 
Kingdom), which signed an inter-governmental treaty. 
Between 2007 and 2012, MAOC-N, which is located in Lisbon, 
Portugal, supported operations that seized 70 tonnes of 
cocaine, with an estimated value of EUR 3 billion, and 50 
tonnes of cannabis (MAOC-N, 2013).
The EU actively engages with its immediate geographical 
neighbours and other regions of the world in undertaking 
cooperation and development work. These activities are 
supported by regional and thematic funding tools. Drug issues 
TABLE 4
Financial programmes and instruments covering drug supply 
reduction activities
EU internal action
Framework programme Security and Safeguarding Liberties
    •  Prevention of and Fight against Crime (ISEC)
EU External Borders Fund
EU external action
Instrument for Stability (IfS)
Instrument for Pre-accession Assistance (IPA)
European Neighbourhood Policy (ENP)
    •  European Neighbourhood and Partnership Instrument (ENPI)
    •  TAIEX (Technical Assistance and Information Exchange)
Development and Cooperation Instrument (DCI)
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programmes are frameworks for project-oriented action 
targeted at regions along known drug trafficking routes, and 
aim at disrupting the trade and alleviating damage to the 
regions through which drugs transit (European Commission, 
2012f). In this context, the EU has financially contributed to 
the Airport Communication Project (AIRCOP) and the Seaport 
Cooperation Programme (SEACOP), designed to interdict 
drugs at air and sea ports. Both programmes are due to run 
between 2010 and 2014, with the EU contributing a total of 
EUR 4.8 million to AIRCOP and EUR 3 million to SEACOP 
(European Commission, 2011b). 
To become Member States of the EU, countries must bring 
their legislation into line with that of the Union. Candidate and 
potential candidate countries receive support through the 
Instrument for Pre-accession Assistance (IPA), which provides 
assistance for transition and institution building, cross-border 
cooperation, regional development, human resources and 
rural development (European Commission, 2012h). The IPA 
makes provision for drug-related projects and assistance 
within its funding activities. For example, the EMCDDA works 
with candidate and potential candidate countries to 
strengthen national capacity to monitor the drug situation 
(EMCDDA, 2013b). 
Candidate and acceding countries receive assistance through 
various EU programmes. These include the European 
Neighbourhood Programme (ENP) and its associated financial 
tools the European Neighbourhood Policy Instrument (ENPI) 
and the Technical Advice and Information Exchange (TAIEX) 
instrument. For example, through TAIEX, support is given to 
the development of drug policy and its coordination in 
candidate countries, where workshops designed to facilitate 
knowledge transfer are held with national and EU experts. This 
contributes to capacity building in the fight against drugs and 
crime.
In other regions of the world where the production and 
trafficking of drugs poses challenges, such as Latin America, 
the EU provides assistance through its Development 
Cooperation Instrument (DCI). Funding under this instrument 
has been invested in the Cooperation Programme between 
Latin America and the European Union on Drugs Policies 
(COPOLAD), for example. Running between 2010 and 2014, 
the programme has a budget of approximately EUR 6.6 million, 
provided by the EU. It focuses on four main objectives: 
strengthening the mechanism for drug policy dialogue 
between the EU and Latin America and the Caribbean, 
supporting the development of national drug observatories, 
and enhancing capacity in demand reduction and supply 
reduction (European Commission, 2012c). EU priorities and 
actions against the threats posed by the production and 
trafficking of illicit drugs are guided by strategic planning tools, 
and the following section looks at these planning instruments 
in the drugs and security fields.
generally, and matters linked to supply reduction, fall within 
the comprehensive scope of the programmes, which are 
based around regional strategy papers with allocated budgets, 
implemented through multi-annual strategies. For example, 
more than EUR 666 million was contributed by the 
Commission in 2006 to projects targeting drug issues — 
mainly through alternative development — in third countries 
such as Afghanistan, where EUR 428 million was spent, and 
Bolivia, Colombia and Peru to the amount of EUR 154 million 
(European Commission, 2011b).
The External Borders Fund (EBF) has financed drug supply 
reduction activities in the context of the external dimension of 
the EU internal security strategy. This has included the 
provision of financial support to regional-level surveillance 
systems that play an important role in the control of the 
Schengen Area’s external borders. For example, the EBF 
contributed to the Spanish ‘Sistema Integrado de Vigilancia 
Exterior’ (SIVE). The SIVE was used to boost maritime 
interdiction activities on the Strait of Gibraltar and other 
coastal areas in the southern Mediterranean (European 
Commission, 2013a). 
In line with the Stockholm Programme on the area of freedom, 
justice and security, the Commission has proposed the 
creation of an internal security fund (ISF) to support the 
implementation of the internal security strategy and related 
activities, including law enforcement cooperation, new 
large-scale information technology systems and external 
border management. The ISF will be part of a reordering of 
funding instruments in the Home Affairs area, reducing the 
number of financial tools from six to two (European 
Commission, 2013d). The fund will finance activities that 
implement the EU policy cycle. As a result of specifications 
under Title V ‘Area of freedom, security and justice’ in the 
Lisbon Treaty (TFEU), the ISF will consist of two separate 
financial instruments, with activities related to drug supply 
reduction being supported through the proposed ‘instrument 
for financial support for police cooperation, preventing and 
combating crime, and crisis management’. When adopted, this 
instrument will run for the period between 2014 and 2020, 
and will lead to the repeal of the Council decision on the ISEC 
programme (Council of the European Union, 2012e). 
The Instrument for Stability (IfS) is used to help prevent, ease 
and address the consequences of both crises and security 
challenges outside the EU. Its use is coordinated by the EU’s 
High Representative, with the EEAS and the Commission 
together deciding on what the instrument is directed at, and 
EuropeAid being responsible for implementation. The 
Commission draws up annual action plans under the 
instrument. Drug supply reduction projects are addressed in 
the context of article 4.1 of the current IfS regulation. It funds 
drug supply reduction activities through both the ‘Cocaine 
Route Programme’ and the ‘Heroin Route Programme’. These 
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way, article 67 seeks to establish the EU as an area where 
citizens are entitled to freedom of movement, the protection 
of their fundamental rights and a high level of security through 
the prevention of and fight against crime. Achieving this vision 
has been a long-term policy objective, which has developed 
incrementally through three successive implementing 
programmes since 1999. These are the Tampere Programme, 
The Hague Programme and the Stockholm Programme. Given 
their focus on creating a secure EU society in line with the 
TFEU, these programmes have addressed issues at the core 
of internal security matters such as external border control, 
judicial and police cooperation and the fight against organised 
crime, including the production and trafficking of drugs 
(Council of the European Union, 2012b; European 
Commission, 2013e).
In the Stockholm Programme (2010–14), the European 
Council identified drug trafficking as a cross-border organised 
crime activity that posed a serious challenge to the EU’s 
internal security, and the response that it called for — in line 
with the Lisbon Treaty (TFEU) — has had a defining impact on 
the area. For example, it tasked the Council of the European 
I Policy framework
Given the complex and far-reaching nature of the problems 
posed by the production and trafficking of illicit drugs, 
responses to these issues span several areas of policy. The 
general approach taken by the EU, its Member States and 
international partners on drug supply reduction issues is 
elaborated in the EU’s internal and external security and drug 
policies. Both of these policy fields have a comprehensive 
scope, extending beyond drug supply reduction. The EU 
internal security policy is concerned with terrorism, 
cybercrime, the activities of organised crime groups, 
trafficking in human beings and the production and supply of 
illicit drugs. Structurally, the EU drug strategies have been 
built around two pillars — demand reduction and supply 
reduction — and three cross-cutting, or transversal, themes 
— coordination, international cooperation, and information, 
research, monitoring and evaluation, an approach now also 
evident in most EU Member States’ drugs strategies. 
Consequently, EU-level drug supply reduction policy forms 
part of these two overarching areas, which complement and 
support each other, where concerns around the illicit drugs 
trade are increasingly situated within the overall context of 
internal and external security challenges. It is predominantly 
these two areas that provide the framework for action against 
the production and trafficking of drugs, where measures 
agreed and designed by the Member States and the EU 
institutions are elaborated (see the section ‘Institutional 
arrangements’), providing the agenda for action undertaken 
with the legal and funding tools at their disposal (see the 
section ‘Legislation and financial programmes’). This section 
of the report looks at how drug supply reduction arises in both 
policy areas and sets out the type of actions being taken. 
I EU internal security policy
Within the context of the European Council’s meetings, the 
government leaders of EU Member States agree the 
overarching political direction that the Union should take in 
key policy areas. It is here, building on the work of the 
European Commission and the Council, that the focus of 
security policy has been endorsed. For example, the spectrum 
of security challenges facing the EU was set out in ‘A secure 
Europe in a better world’, the EU external security strategy, 
approved by the European Council in 2003. It identified 
organised crime and drug trafficking as important threats both 
within and outside the EU, alongside terrorism, the 
proliferation of weapons of mass destruction, regional 
conflicts and state failure (European Council, 2003).
The origins of the EU’s approach to internal security are 
closely bound up with the Lisbon Treaty (TFEU) and a set of 
other developments (Table 5). Title V of the treaty addresses 
the ‘area of freedom, security and justice’. In an overarching 
TABLE 5
Timeline of EU internal security developments
1999 The Tampere Programme
The Schengen acquis
2003 EU external security strategy 
2004 Comprehensive Operational Strategic Planning for the Police 
(COSPOL)
The Hague Programme
2005 Action plan implementing the Hague Programme
Council conclusions on intelligence-led policing and the 
development of the Organised Crime Threat Assessment 
(OCTA)
EU Organised Crime Report
2006 EU Organised Crime Threat Assessment 
2008 Report on the implementation of the external security strategy
Council framework decision on the fight against organised 
crime
2009 Council Decision on setting up the Standing Committee on 
Operational Cooperation on Internal Security 
2010 Stockholm Programme 
Stockholm action plan
Internal security strategy
Internal security strategy in action
Council conclusions on the creation and implementation of an 
EU policy cycle on organised and serious crime
2011 Council conclusions on setting the EU’s priorities for the fight 
against organised crime between 2011 and 2013
Policy advisory document for the years 2011 to 2013
Amending the COSPOL framework into the European 
Multidisciplinary Platform against Criminal Threats (EMPACT)
2012 EMPACT terms of reference
2013 EU Serious and Organised Crime Threat Assessment (SOCTA)
Council conclusions on setting the EU’s priorities for the fight 
against serious and organised crime between 2014 and 2017
Policy advisory document for the years 2014 to 2017
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borders will be developed, alongside increasing interagency 
cooperation at the national level, through common risk 
analysis and the improvement of border checks (European 
Commission, 2010b). 
The Commission has set out this agenda, as its role in the 
decision-making process at the EU level includes proposing 
legal acts and assessing the impact of existing ones. In this 
sense, the Commission has proposed new legal acts on a 
range of issues. These are designed to update existing 
legislative tools so that EU actions target organised crime 
more effectively. Among the proposals are a fourth anti-money 
laundering directive coupled with a fund transfer regulation, a 
directive on the freezing and confiscation of the proceeds of 
crime in the EU, and amendments to two existing Council 
decisions on new psychoactive substances and drug 
trafficking penalties (European Commission, 2013a).
I  Policy cycle on organised and serious  international crime
Building effective cooperation mechanisms for the EU and its 
Member States and the development of intelligence-led 
policing are fundamental components of the EU’s approach to 
tackling organised crime. This has been interlinked with the 
creation of organised crime threat assessments and the work 
of Europol. In the Hague Programme (2004–09), Europol was 
requested to change its intelligence reports from the format of 
organised crime situation reports to ‘threat assessments’ of 
serious crime. The method supporting the assessments 
involves the Member States providing data in the form of an 
‘intelligence requirement’ through their Europol national units. 
Once received, the data is combined with Europol’s analysis 
work files to produce the OCTA. The resulting assessment 
functions as a priority-setting tool for the Council’s working 
groups and coordination platforms (Council of the European 
Union, 2005a). 
Arising from the Council’s 2005 conclusions on intelligence-
led policing, a European criminal intelligence model (Figure 3) 
was designed and refined over several years. The model 
integrated the full cycle of activities behind building 
operational intelligence on organised crime groups, setting 
priorities and taking coordinated action. Within this process, 
the Comprehensive Operational Strategic Planning for the 
Police (COSPOL) platform was used to implement and 
support the criminal intelligence model. COSPOL was initiated 
in 2004 as a platform to facilitate operational cooperation in 
law enforcement. The platform and the projects it ran were 
placed under auspices of the European Police Chiefs Task 
Force (EPCTF) (Council of the European Union, 2005a, 
2009a). 
Union (the Council) and the European Commission with 
creating an EU internal security strategy grounded in, among 
other things, cooperation and intelligence-led policing. Within 
the framework of this overall strategy, it also requested the 
Council and the Commission to develop a specific strategy to 
address organised crime (the ‘policy cycle’, see below), to 
prioritise the types of crime to be targeted, and to utilise 
Europol’s European and regional Organised Crime Threat 
Assessments (OCTA) to inform planning. In building mutual 
support between policy areas, the Council and the 
Commission were also asked to ensure that the 2013–20 EU 
drugs strategy supported the internal security strategy and 
complemented the specific organised crime strategy. In this 
way, drug supply reduction activities are addressed in both 
policy areas in an integrated way. The European Council also 
made the Commission responsible for assessing the 
feasibility of establishing an Internal Security Fund (ISF) to 
support the security strategy (Council of the European Union, 
2012e; European Council, 2010b). 
In 2010, the European Council endorsed the internal security 
strategy ‘Towards a European security model’, supporting the 
development of the EU as an area of freedom, justice and 
security. It was designed to integrate existing work on internal 
security and complement the framework provided by the 
Stockholm Programme in addressing security threats. In 
responding to, among other things, organised and serious 
crime, drug trafficking and cross-border crime, it underlined the 
importance of cooperation between law enforcement, judicial 
and border control authorities. The strategy also acknowledged 
the central role of intelligence-led policing and early-warning 
and risk assessment processes in supporting EU action, 
particularly the work of COSI (European Council, 2010a). 
The main objectives and actions around which existing 
internal security activities and their development are based 
have been elaborated by the Commission. In a document on 
the internal security strategy, the Commission set out five 
objectives and supporting actions. For example, drug supply 
reduction issues are covered under the objective of disrupting 
international crime networks. This is implemented through 
reviewing legislation on money laundering, supporting use of 
the European arrest warrant, encouraging more use of joint 
investigation teams, strengthening anti-corruption measures 
and the establishment of asset recovery offices by the 
Member States. Similarly, action against drug trafficking is 
addressed through the objective of strengthening security 
through border management. Implementation activities here 
include the establishment of the European Border 
Surveillance System (EUROSUR) to enhance the detection 
and tracking of maritime vessels smuggling drugs. 
Complementing this, initiatives to strengthen risk analysis and 
targeting of illicit goods being moved across the EU’s external 
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Source: Adapted from Council of the European Union (2009a).
Following on from the COSPOL projects, the Council 
supported the creation of the Harmony project, in 
collaboration with the European Commission through its 
framework programme ‘Prevention of and fight against crime’. 
The Harmony project contributed to the design of the policy 
cycle adopted by the Council in 2010, which is sometimes 
referred to as the ‘harmony process’, as a result of its bringing 
all the relevant actors and tools together (Council of the 
European Union, 2010b, 2010d). 
In 2009, the entry into force of the Lisbon Treaty removed the 
three pillars of the EU and established the European Union, 
resulting in increased legislative powers in the policy areas 
that had previously been subject to intergovernmental 
cooperation (i.e. the second and third pillars) (European 
Commission, 2010c). Article 71 of the Treaty (TFEU) called for 
the creation of the Standing Committee on Operational 
Cooperation on Internal Security (COSI), which was 
established by a Council decision in 2009. Bringing together 
the Member States’ representatives, COSI is responsible for 
the facilitation of operational cooperation among competent 
authorities at the national level for internal security and for the 
evaluation of activities in this area. Although it is required to 
support the Council and report to the Parliament, it is not 
involved in undertaking operational activities, which are the 
responsibility of Member States, or the preparation of 
legislation (Council of the European Union, 2009b). 
As a result of the Stockholm Programme, COSI was given 
responsibility for implementing the EU internal security 
strategy (Council of the European Union, 2010a). Within the 
context of this work, COSI developed the policy cycle for 
organised and serious international crime, within which it 
plays a leading role in defining, implementing, monitoring and 
evaluating the EU’s activities against organised crime (Council 
of the European Union, 2010b). 
Building on the approach defined in the Council’s ‘Architecture 
of internal security’ and the Harmony project, the Council set 
out conclusions on the policy cycle in 2010 (Council of the 
European Union, 2006a, 2010b, 2010d). It elaborated an 
action plan for both the initial (2011–13) and full (2014–17) 
phases of the policy cycle and the overarching steps in the 
process. These are: (1) policy development, (2) priority setting, 
(3) implementation and monitoring, and (4) evaluation of the 
current policy cycle and definition of the next one.
The process involves the Presidency of the Council, COSI and 
the European Commission developing a policy advisory 
document (PAD) based on the SOCTA. This document is then 
used by the Council to agree conclusions, drafted by COSI, 
which define the crime priorities in the policy cycle — it is the 
Council’s responsibility to make political decisions in the 
Justice and Home Affairs area. Subsequently, multi-annual 
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In this way, the policy cycle — like the EU drugs strategy 
2013–20’s supply reduction measures — contributes to the 
implementation of the EU internal security strategy’s objective 
to disrupt international crime networks (European 
Commission, 2013e). This supports the development of the 
EU’s area of freedom, justice and security as set out in the 
Lisbon Treaty (TFEU) and the Stockholm Programme. 
Similarly, the strategic goals identified during the initial phase 
of the policy cycle functioned to implement the ‘European 
pact to combat international drug trafficking — disrupting 
cocaine and heroin routes’ and the ‘European pact against 
synthetic drugs’. These two targeted planning tools 
reinvigorated and focused the political will to address these 
supply reduction issues, and their aims fed into the goals of 
the policy cycle (Council of the European Union, 2010c, 
2011c). 
A core part of the policy cycle is the mechanism used to 
implement operational actions. The Council redesigned the 
COSPOL platform as the European Multidisciplinary Platform 
against Criminal Threats (EMPACT) in 2011 (see the box on 
EMPACT). Action 5 of the policy cycle required COSI and the 
Commission to review the COSPOL terms of reference in 
order to bring the platform into line with the policy cycle and 
give it the capacity to implement the operational actions 
(Council of the European Union, 2011d). To reflect the 
experience gained in planning the policy cycle and the 
multidisciplinary nature of the project, the Council renamed 
the platform as EMPACT (Council of the European Union, 
2011a). In developing the tools needed to support the policy 
cycle, actions 1, 2 and 4 of the action plan focused on the 
development of Europol’s SOCTA. Whereas Europol’s 2011 
OCTA had been used for priority setting in the initial phase of 
the policy cycle, the 2013 SOCTA was used to develop the 
priorities for the full policy cycle, supporting action 26 in the 
action plan (Council of the European Union, 2010b; Europol, 
2011, 2013). 
strategic plans (4) are established and implemented through 
operational action plans, both of which are developed by the 
Member States, the Commission and the EU agencies under 
COSI’s coordination. Following this, project groups are 
established to manage each operational action plan (Figure 4) 
(Council of the European Union, 2010b). 
(4)  During the initial phase, strategic goals were adopted, but not referred to as 
multi-annual strategic plans (Council of the European Union, 2010b).
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from a focus on (geographic) criminal hubs in the OCTA, to 
one structured around illicit commodities in the SOCTA, based 
on the simultaneous involvement of organised crime groups in 
multiple illegal activities, resulted in a revised set of priorities 
for the full policy cycle (see Table 6). This reflects the fact that 
some activities are being addressed through other EU 
mechanisms and processes, but will still be taken into account 
when designing the specific actions in the operational action 
plans (Council of the European Union, 2013d). Following 
action 40 of the policy cycle’s action plan, an interim 
assessment of the full cycle (2014–17) will be prepared in 
2015, identifying and recommending modifications to the 
priorities (Council of the European Union, 2010b).
The policy cycle approach does not involve all Member States 
participating in all actions. Rather, those most affected by 
specific criminal threats take part in the operational actions 
targeting them. Other Member States with proven experience 
in responding to particular types of crime problems may also 
be involved in supporting the actions (Council of the European 
Union, 2013d). 
As a feedback-oriented process, the policy cycle is designed 
to support the adjustment of crime priorities so that they 
remain up-to-date, build on the lessons learned from the initial 
policy cycle and take into account other EU-level work 
addressing the activities being targeted. In this sense, a move 
Replacing the COSPOL framework within the European 
criminal intelligence model (Figure 3), EMPACT functions as 
the coordination platform for the EU Member States and 
institutions to implement operational law enforcement 
actions. It provides a structure to develop and manage 
actions supporting the policy cycle. Bringing together 
representatives from the Member States, EU agencies, 
public and private organisations, and third countries, it is 
multidisciplinary in nature (see the graphic below, ‘EMPACT 
participants’). It is here that the crime priorities agreed by 
the Member States’ representatives at COSI are 
implemented by National EMPACT Coordinators (NECs). 
Holding a senior law enforcement position of a strategic 
nature, the NECs must have the authority to implement the 
projects agreed. They must assess the need for and ability 
of their respective countries to participate in addressing a 
crime priority, monitor implementation of the action and 
report to Europol and COSI on it. 
Europol plays a central role through its EMPACT support 
unit, which provides administrative and logistical support to 
the platform, as well as monitoring the progress of projects. 
It assigns an official to manage each project. When the 
operational action plans, validated by COSI, supporting the 
policy cycle are designed, a lead country and a back-up 
— known as the driver and co-driver — are assigned to lead 
the project group implementing the joint actions. Projects 
— one per crime priority — are generally scheduled to run 
for 12-month periods. COSI requests Member States to 
integrate the actions implementing the operational action 
plans into their national planning and to provide supporting 
resources. Both the European Commission and the EU 
agencies make provision for participation in EMPACT 
projects. COSI is responsible for evaluating EMPACT, and 
has designed its terms of reference (Council of the 
European Union, 2012c, 2013a).
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tool, to express drug policies. Drug supply reduction activities 
are a central component of this model for expressing drug 
policy, which provides orientation and coordination for action. 
Below, EU supply reduction activities are discussed in the 
context of the EU drugs strategy 2013–20 and its action plan 
2013–16. 
The EU legal infrastructure is constantly evolving in response 
to the dynamic and shifting nature of the problems posed by 
the production and trafficking of drugs. This is visible both at 
the treaty level in the general JHA area and in the specific 
legislative tools that enable cross-border policing and judicial 
action. Similarly, new EU-level drug strategies and action 
plans are adopted as old ones expire, in order to restate 
support for the action being taken, as well as to re-orient and 
update that work. In 2012, the EU adopted its sixth drugs 
strategy since 1990 (Table 7). As the EU drugs strategies and 
action plans extend over both long and short periods of time, 
actions initiated under an earlier strategy or action plan may 
continue to run under, and give support to, subsequent 
strategies or action plans. 
It is in these EU-level drug strategies and action plans that the 
main principles, objectives, priorities and actions addressing 
drug issues generally are elaborated. This is done across the 
two pillars of demand reduction and supply reduction and the 
three cross-cutting themes of coordination, international 
cooperation, and information, research, monitoring and 
evaluation (Figure 5). This conceptual architecture provides a 
coherent framework for mapping, assessing and structuring 
activity, and has been increasingly adopted at the national 
level by EU Member States in their drug policies. The equal 
focus placed on demand reduction and supply reduction 
activities, where both elements reinforce each other, is the 
central principle of the ‘balanced approach’ to drug policy. 
TABLE 6
Key priorities related to drug supply reduction in the  
policy cycle
Initial cycle: 2011–13
Weaken the capacity of organised crime groups active or based in 
West Africa to traffic cocaine and heroin to and within the EU
Mitigate the role of the Western Balkans as a key transit and storage 
zone for illicit commodities destined for the EU and logistical centre 
for organised crime groups, including Albanian-speaking organised 
crime groups
Reduce the production and distribution in the EU of synthetic drugs, 
including new psychoactive substances
Disrupt the trafficking to the EU, particularly in container form, of illicit 
commodities, including cocaine, heroin, cannabis, counterfeit goods 
and cigarettes
Full cycle: 2014–17
Reduce the production of synthetic drugs in the EU and disrupt the 
organised crime groups involved in synthetic drugs trafficking
Reduce cocaine and heroin trafficking to the EU and disrupt the 
organised crime groups facilitating the distribution of these drugs in 
the EU
NB: This table does not list all of the policy cycle’s crime priorities
Source: Council of the European Union (2011b, 2013b).
The policy cycle represents the culmination of EU efforts to 
develop an effective priority-setting and operational 
cooperation mechanism between the Union and the Member 
States. It reflects the EU’s commitment to the evaluation and 
modification of policies based on the experiences gained and 
the upgrading of the supporting infrastructure. In line with 
action 20 of the policy cycle’s action plan, the European 
Commission evaluated the initial phase of the policy cycle and 
used the results to support the implementation of the full 
cycle. The evaluation identified the need to strengthen the 
engagement of the Member States in the policy cycle and the 
EMPACT platform, and to define the strategic goals so that 
they are more conducive to the design of operational EMPACT 
activities. The Commission underlined the need for flexibility 
in the process, in order to allow for the termination of actions 
and projects that are no longer relevant or not being achieved, 
and the importance of conveying information to Europol. The 
evaluation also noted the need to simplify the funding process 
and establish synergies with EU actions in the external 
security area (Council of the European Union, 2013a). 
I EU drugs policy
Since 1990, the EU and its Member States have used the 
format of a strategic (long-term) planning document, 
increasingly supported by an operational (short-term) planning 
TABLE 7
Timeline of EU drugs strategies
1990 First European action plan to combat drugs
1992 Second European action plan to combat drugs
1995 EU drugs action plan 1995–99
2000 EU drugs strategy 2000–04
EU drugs action plan 2000–04
2005 EU drugs strategy 2005–12
EU drugs action plan 2005–08
2009 EU drugs action plan 2009–12
2012 EU drugs strategy 2013–20
2013 EU drugs action plan 2013–16
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FIGURE 5
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Both strategies and action plans are designed by the 
Member States under the coordination of the Presidency of 
the Council and the HDG, and adopted by the Council at the 
JHA configuration. The framework provided by the EU drugs 
strategy 2013–20 and its current (2013–16) and subsequent 
(2017–20) action plans is designed to complement the 
Member States’ national strategies and to support joint 
actions. The strategy seeks to ensure an effective and 
efficient use of the resources available to address drug 
problems. In the area of supply reduction, it has identified 
several challenges. These include the dynamic nature of 
illicit drugs markets, changes in trafficking routes, and the 
role of cross-border organised crime and new technologies in 
the trafficking of illicit drugs and new psychoactive 
substances. In addition, the strategy has noted the 
importance of preventing the diversion of drug precursors 
and cutting agents from licit industry that can be used to 
manufacture illicit drugs. In an overarching sense, the 
strategy responds to these challenges through its objective 
to disrupt drug markets and limit the availability of illicit 
drugs (see the box ‘Supply reduction in the EU drugs 
strategy’) (Council of the European Union, 2012d).
In meeting this objective, a number of priorities have been set 
out in the strategy, which are then translated into supporting 
objectives and specific actions in the EU drugs action plan 
2013–16 (Table 8). Here, drug supply reduction and internal 
security issues are clustered around a number of themes, 
where actions are undertaken by EU institutions, working 
groups and agencies in conjunction with the Member States, 
through cooperation platforms. Utilising and updating the EU’s 
legal tools plays an important role in implementing the action 
plan. For example, the design and adoption of new legislative 
measures underpins the achievement of measures against 
drug trafficking, money laundering (action 17), the availability 
of new psychoactive substances (action 18), the diversion of 
drug precursors (action 19) and the use of certain chemicals 
as cutting agents (action 20). The collection and use of 
information to support intelligence-led policing forms a central 
part of the EU response to drug production and trafficking. 
This includes measures designed to make effective use of law 
enforcement information to support joint investigation teams, 
joint customs operations, judicial and law enforcement 
cross-border cooperation activities and EMPACT projects 
(action 10). Similarly, providing support to cooperation 
platforms that facilitate information exchange is aimed at 
tackling new threats arising from shifts in drug supply routes 
(action 13), whereas the development of key indicators on 
drug supply reduction seeks to improve monitoring of the drug 
markets (action 16) (Council of the European Union, 2013e). 
The overarching objective of the EU drugs strategy 
2013–20 in the area of supply reduction is a measurable 
reduction of the availability of illicit drugs, through:
–  the disruption of illicit drug trafficking;
–  the dismantling of organised crime groups that are 
involved in drug production and trafficking; 
–  efficient use of the criminal justice system; 
–  effective intelligence-led law enforcement and 
increased intelligence sharing; 
–  an EU-level emphasis on large-scale, cross-border and 
organised drug-related crime. 
Source: Reproduced from Council of the European Union (2012d).
Supply reduction in the EU drugs strategy
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I Conclusions 
Recent decades have been marked by shifts in the production 
and trafficking of illicit drugs. Globalisation, characterised by 
the increased movement of people and goods across the 
world, together with the near-universal use of the Internet, has 
sustained illicit drug markets. New methods of manufacturing 
drugs are devised to bypass controls on drug precursors by 
using pre-precursors and unscheduled drug precursors. While 
laws are being adopted to restrict the sale of new 
psychoactive substances, molecules are tweaked in illicit 
laboratories to evade bans. The Internet — an integral means 
of organising the production, trafficking, distribution and sale 
of illicit drugs — remains unregulated, while financial systems 
are manipulated to disguise the proceeds of crime.
The EU and its Member States have reacted to the activities of 
organised crime groups by taking the threats they pose into 
account when updating Union legislation. EU treaties provide 
legal support for a range of counter-measures that are 
implemented through specific and targeted legal acts 
designed to facilitate cooperation between the Member 
States in tackling drug production and trafficking. In 
attempting to hit this moving target, the use of legal tools is 
monitored so that appropriate revisions can be made to keep 
pace with changes in the behaviour of organised crime groups 
and in the technologies that support their activities. 
Through a set of complementary strategic planning tools, the 
EU targets its work and builds operational cooperation among 
national authorities and international partners. At all levels of 
the EU institutions, the Member States and their 
representatives guide action, deciding the powers needed and 
the measures to be taken. This reflects the coordinated and 
shared approach taken by the EU and its Member States in 
responding to organised crime and drug trafficking. 
The establishment of the EU as an area of freedom, justice 
and security has been one of the Union’s defining 
achievements. However, this development remains subject to 
challenges posed by the activities of criminals within and 
outside the EU’s external borders. An intelligence-led 
approach to law enforcement and internal security has been 
adopted by the EU. It is underpinned by strategic data 
collection, analysis and information sharing across areas 
impacted by organised crime. Measures are designed, 
implemented, evaluated and adapted to keep pace with 
changes in the supply of illicit drugs. Here, the Member States, 
EU institutions and agencies work together and use EU and 
national legal tools to deliver a targeted response to illicit drug 
markets. 
Both the policy cycle and the EU drugs strategy contribute to 
the implementation of the EU internal security strategy 
(European Commission, 2013a). These strategic tools and 
their accompanying action plans are designed to complement 
each other, so that actions being implemented under one 
strategy are taken account of in the other. This avoids 
duplication of efforts, provides effective coordination of 
EU-level policy actors and ensures that all aspects of drug 
supply reduction are covered through the EU internal security 
and general drugs strategies. For example, objective 4 of the 
drugs action plan is aimed at building ‘effective law 
enforcement cooperation and coordination […] in coherence, 
as appropriate, with relevant actions determined through the 
EU policy cycle’. COSI is involved in managing the 
implementation of five of the 13 actions addressing supply 
reduction issues in the drugs action plan (Council of the 
European Union, 2013e). This supports the European Council’s 
request in the Stockholm Programme for the Council and the 
Commission to develop a drugs strategy that complements 
and takes into consideration the EU internal security strategy 
and the policy cycle (European Council, 2010b).
Reflecting this approach in practice, action 11 of the drugs 
action plan seeks to ‘identify and prioritise the most pressing 
threats associated with drug-related organised crime’. This is 
implemented through the work of Europol in developing its 
SOCTA, the creation of a policy advisory document by the 
Commission and COSI, and the adoption of Council 
conclusions setting out the crime priorities for the full policy 
cycle between 2014 and 2017 (Council of the European Union, 
2013e). Similarly, the EMPACT platform supports six of the 13 
actions addressing supply reduction in the drugs strategy, 
reflecting the level of synergy between drug supply reduction 
and internal security tools. This is evident, for example, in 
responding to developments in communication technologies, 
particularly the Internet, which facilitate the illicit drugs trade 
(action 22), where EMPACT is a source of law enforcement 
information. In this context, it is important to remember that 
the EU drugs strategy is a comprehensive tool, covering 
internal and external actions by the Union. Consequently, it 
takes account of related strategic instruments, such as the 
policy cycle, in order to meet related objectives, such as 
identifying the main criminal threats facing the EU. 
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Eurojust The European Union’s judicial cooperation unit
Europol The European Police Office 
EUROSUR European Border Surveillance System
Frontex European Agency for the Management of 
Operational Cooperation at the External Borders 
of the Member States of the European Union
GAC General Affairs (configuration of the Council of the 
EU)
HDG Horizontal Working Party on Drugs
High 
Representative
High Representative of the Union for Foreign 
Affairs and Security Policy
IfS Instrument for Stability
IPA Instrument for Pre-accession Assistance
ISEC Prevention of and Fight against Crime 
ISF Internal Security Fund
JCO Joint customs operations
JHA Justice and Home Affairs (configuration of the 
Council of the EU)
JIT Joint investigation teams
LEWP Law Enforcement Working Party
LIBE Civil Liberties, Justice and Home Affairs 
Committee (European Parliament)
MAOC-N Maritime Analysis Operation Centre — Narcotics 
MASP Multi-annual strategic action plan
MFF Multi-annual financial framework
MS Member States (of the European Union)
NEC National EMPACT Coordinator
OCTA Organised Crime Threat Assessment 
PAD Policy advisory document 
PR Presidency of the Council of European Union 
PSC Political and Security Committee 
Reitox Réseau Européen d’Information sur les Drogues 
et les Toxicomanies (the EMCDDA’s network of 
national focal points)
SEACOP Seaport Cooperation Programme
SEDE Security and Defence Committee (European 
Parliament)
SIVE Sistema Integrado de Vigilancia Exterior 
(integrated external vigilance system)
SOCTA Serious and Organised Crime Threat Assessment 
TAIEX Technical Assistance and Information Exchange
TE-SAT EU Terrorism Situation and Trend Report
TEU Treaty on European Union (Lisbon Treaty)
TFEU Treaty on the Functioning of the European Union 
(Lisbon Treaty) 
UNODC United Nations Office on Drugs and Crime
I Abbreviations
Abbreviations and terms commonly used in the fields of 
supply reduction and internal security are provided here. 
Although including all the relevant abbreviations found in this 
publication, please note that the list is not comprehensive. 
AFET Foreign Affairs Committee (European Parliament)
AIRCOP Airport Communication Project
AWF Analysis work file (Europol)
BOMCA Border Management Programme in Central Asia
CABSI Central Asia Border Security Initiative 
CADAP Central Asia Drug Action Programme
CARIN Camden Asset Recovery Inter-Agency Network 
CATS Coordinating Committee in the area of police and 
judicial cooperation in criminal matters
CCWP Customs Cooperation Working Party
Cepol European Police College
CFSP Common Foreign and Security Policy
COMPET Competitiveness (configuration of the Council of 
the EU)
COPOLAD Cooperation Programme between Latin American 
and European Union on Drug Policies
Coreper Permanent Representatives Committee (at the 
Council of the EU)
COSI Standing Committee on Operational Cooperation 
on Internal Security 
COSPOL Comprehensive Operational Strategic Planning 
for the Police 
CRIM Special Committee on Organised Crime, 
Corruption and Money Laundering (European 
Parliament)
CSDP Common Security and Defence Policy
CUG Working Party on Customs Union
DG Directorate-general (at the Council of the EU, the 
EU Parliament or the EC)
EAW European arrest warrant
EBF External Borders Fund
ECIM European criminal intelligence model
EEAS European External Action Service 
EEW European evidence warrant
EILCS Europol illicit laboratory comparison system 
EIXM European information exchange model 
ELOs Europol liaison officers
EMCDDA European Monitoring Centre for Drugs and Drug 
Addiction 
EMPACT European Multidisciplinary Platform against 
Criminal Threats
EMPACT SU EMPACT support unit
ENU Europol national units
EPCTF European Police Chiefs Operational Task Force 
(also known as ‘TFPC’)
EU European Union
EU INTCEN European Union Intelligence Analysis Centre 
(formerly SITCEN)
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